中文 | English
Return
Total: 364 , 1/37
Show Home Prev Next End page: GO
Author:(Xue-Ming YI)

2.A new model-tracking of ?-cell development by generation of transgenic zebrafish

Ming XIA ; Xue PAN ; Ming DENG ; Yi JIN ; Yi CHEN ; Hesheng WANG ; Deming KONG

Basic & Clinical Medicine 2006;0(07):-

5.Pharmacokinetic comparison of roxithromycin under normoxic and hypoxic conditions in rats by UPLC/MS/MS

Tao SHAO ; Yi QIN ; Pingxiang XU ; Weizhe XU ; Liang ZHAO ; Yi MA ; Weijia HAO ; Ming XUE

Chinese Pharmacological Bulletin 2016;32(11):1596-1600,1601

6.The mechanism of rosiglitazone compound based on network pharmacology.

Yu BAI ; Xue-mei FAN ; Han SUN ; Yi-ming WANG ; Qiong-lin LIANG ; Guo-an LUO

Acta Pharmaceutica Sinica 2015;50(3):284-290

7.Nanoscale drug carriers for traditional Chinese medicine research and development.

Cheng-xue YI ; Jiang-nan YU ; Xi-ming XU

China Journal of Chinese Materia Medica 2008;33(16):1936-1940

8.Research on individual sleep staging based on principal component analysis and support vector machine.

Peng ZHOU ; Xiangxin LI ; Yi ZHANG ; Dong MING ; Xinming DONG ; Ranting XUE ; Xuemin WANG

Journal of Biomedical Engineering 2013;30(6):1176-1179

9.Studies on the interaction between troxerutin and bovine serum albumin

Lijuan WANG ; Xiaorong LI ; Yuhang LI ; Yanxia XU ; Xiaomin HU ; Yi CHEN ; Yuanjie FAN ; Ming XUE

Chinese Pharmacological Bulletin 2009;25(12):1584-1588

10.Study on inhibitory effects and mechanism of lipophilic components in Salvia miltiorrhiza on angiogenesis in vitro.

Xue-Mei FAN ; Gui-Xiang REN ; Qiong-Lin LIANG ; Yi-Ming WANG ; Guo-An LUO

China Journal of Chinese Materia Medica 2014;39(4):744-747

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 364 , 1/37 Show Home Prev Next End page: GO